FDA: Fresenius Kabi USA recalls one lot of Sensorcaine-MPF (bupivacaine HCL)

Editor's Note

The Food and Drug Administration (FDA) on April 26 announced the recall by Fresenius Kabi USA (Lake Zurich, Illinois) of one lot of Sensorcaine-MPF (bupivacaine HCL) Injection, USP, 0.75%, 7.5 mg/mL, 30 mL fill in a 30 mL vial.

The recall was initiated because of the presence of visible particulate matter characterized as glass found by the company during inspection of reserve samples.

The recall affects Lot Number 6111504; Product Code 470237.

Posted [04/26/2016] AUDIENCE: Surgery, Dentistry, OBGYN, Nursing, Pharmacy ISSUE: Fresenius Kabi USA announced today it is voluntarily recalling a single lot (Lot Number 6111504; Product Code 470237) of Sensorcaine®-MPF (bupivacaine HCl) Injection, USP, 0.75%, 7.5 mg/mL, 30 mL fill in a 30 mL vial.